HC Wainwright & Co. Reiterates Buy on Renalytix, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Renalytix (NASDAQ:RNLX) and maintained a $5 price target.

June 05, 2023 | 4:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Renalytix (NASDAQ:RNLX) receives a reiterated Buy rating from HC Wainwright & Co. analyst Yi Chen, with a maintained $5 price target.
The reiterated Buy rating from HC Wainwright & Co. analyst Yi Chen indicates a positive outlook for Renalytix's stock price in the short term. The maintained $5 price target suggests that the analyst believes the stock has potential for growth. This news is highly relevant and important for investors in RNLX, as it provides an expert opinion on the stock's potential performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100